The report covers forecast and analysis for the veterinary anti-infectives market on a global and regional level. The study provides historic data of 2016 along with a forecast from 2017 to 2022 based revenue (USD Million). The study includes drivers and restraints for the veterinary anti-infectives market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the veterinary anti-infectives market on a global level.


In order to give the users of this report a comprehensive view of the veterinary anti-infectives market, we have included competitive landscape and analysis of Porters Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein species type segment, drug class segment and end-user segments are benchmarked based on their market size, growth rate, and general attractiveness.


The report provides company market share analysis in order to give a broader overview of the key players in the market. In addition, the report also covers key strategic developments of the market including acquisitions mergers, new technology launch, agreements, partnerships, collaborations joint ventures, research development, technology and regional expansion of major participants involved in the market on the global and regional basis. Moreover, the study covers price trend analysis, the product portfolio of various companies according to the region.


The study provides a decisive view on the veterinary anti-infectives market by segmenting the market based on species type, drug class, mode of administration, end-user and regions. All the segments have been analyzed based on present and future trends and the market is estimated from 2016 to 2022. Based on species type the market is segmented into livestock and companion animals. Based on drug class the market is segmented into antimicrobial agents, antiviral agents, antifungal agents and antiparasitic agents. On the basis of mode of administration, the market is segmented into oral, parenteral and topical. Key end-users covered under this study include veterinary hospitals, veterinary clinics, pharmacies and others. The regional segmentation includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America and Middle East Africa with its further bifurcation into major countries including the U.S., Canada, Rest of North America, Germany, U.K., France, Italy, Spain, Russia, Rest of Europe, China, Japan, India, Australia, Rest of Asia Pacific, Brazil, Mexico, Argentina, Rest of Latin America, Saudi Arabia, UAE, Qatar, South Africa and Rest of Middle East and Africa. This segmentation includes demand for veterinary anti-infectives based on individual species type, drug class, mode of administration and end-users in all the regions and countries.


The report also includes detailed profiles of end players such as Bayer AG, Dechra Pharmaceuticals Ltd., Neogen Corporation, Phibro Animal Health Corporation, Vetoquinol S.A., Intas Pharmaceuticals, Inc., Ceva Sant Animale, Zydus Animal Health Limited, Cipla Limited, Heska Corporation, Virbac S.A., Zoetis, Inc., and Elanco Animal Health (Eli Lilly and Company).


This report segments the global veterinary anti-infectives market as follows:


Global Veterinary Anti-Infectives Market: Species Type Segment Analysis

Livestock

Companion

Global Veterinary Anti-Infectives Market: Drug Class Segment Analysis

Antimicrobial Agents

Antiviral Agents

Antifungal Agents

Antiparasitic Agents

Global Veterinary Anti-Infectives Market: Mode of Administration Segment Analysis

Oral

Parenteral

Topical

Global Veterinary Anti-Infectives Market: End-user Segment Analysis

Veterinary Hospitals

Veterinary Clinics

Pharmacies

Others

Global Veterinary Anti-Infectives Market: Regional Segment Analysis

North America


U.S.

Europe


UK

France

Germany

Asia Pacific


China

Japan

India

Latin America


Brazil

Middle East and Africa